Acute Respiratory Disease in US Army Trainees 3 Years After Reintroduction of Adenovirus Vaccine

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2016 Oct 18

PMID 27748651

Citations 16

Authors

Nakia S Clemmons

Zachary D McCormic

Joel C Gaydos

Anthony W Hawksworth

Nikki N Jordan

Affiliations

Soon will be listed here.

Abstract

The 1999 cessation of vaccination against adenovirus types 4 and 7 among US Army trainees resulted in reemergence of acute respiratory disease (ARD) outbreaks. The 2011 implementation of a replacement vaccine led to dramatic and sustained decreases in ARD cases, supporting continuation of vaccination in this population at high risk for ARD.

Citing Articles

User-Friendly Replication-Competent MAdV-1 Vector System with a Cloning Capacity of 3.3 Kilobases.

Zhang Z, Guo X, Hou W, Zou X, Wang Y, Liu S Viruses. 2024; 16(5).

PMID: 38793642 PMC: 11126015. DOI: 10.3390/v16050761.

The Biodistribution of Replication-Defective Simian Adenovirus 1 Vector in a Mouse Model.

Chen J, Guo X, Zou X, Wang M, Yang C, Hou W Viruses. 2024; 16(4).

PMID: 38675893 PMC: 11054548. DOI: 10.3390/v16040550.

Global Prevalence of Preexisting Antibodies against Human Adenoviruses, Surveyed from 1962 to 2021.

Luo H, Zhou Q, Feng J, Wu Y, Chen H, Mao M Intervirology. 2024; 67(1):19-39.

PMID: 38452738 PMC: 11006277. DOI: 10.1159/000538233.

Live Oral Adenovirus Type 4 and Type 7 Vaccine Induces Durable Antibody Response.

Collins N, Adhikari A, Yang Y, Kuschner R, Karasavvas N, Binn L Vaccines (Basel). 2020; 8(3).

PMID: 32718082 PMC: 7564809. DOI: 10.3390/vaccines8030411.

Human Adenovirus Type 55 Distribution, Regional Persistence, and Genetic Variability.

Hang J, Kajon A, Graf P, Berry I, Yang Y, Sanborn M Emerg Infect Dis. 2020; 26(7):1497-1505.

PMID: 32568062 PMC: 7323512. DOI: 10.3201/eid2607.191707.

References

Lee S, Eick A, Ciminera P . Respiratory disease in Army recruits: surveillance program overview, 1995-2006. Am J Prev Med. 2008; 34(5):389-95. DOI: 10.1016/j.amepre.2007.12.027. View

Sivan A, Lee T, Binn L, Gaydos J . Adenovirus-associated acute respiratory disease in healthy adolescents and adults: a literature review. Mil Med. 2007; 172(11):1198-203. DOI: 10.7205/milmed.172.11.1198. View

Hawksworth A . Surveillance snapshot: adenovirus among U.S. military recruit trainees. MSMR. 2012; 19(3):5. View

Broderick M, Hansen C, Russell K, Kaplan E, Blumer J, Faix D . Serum penicillin G levels are lower than expected in adults within two weeks of administration of 1.2 million units. PLoS One. 2011; 6(10):e25308. PMC: 3186770. DOI: 10.1371/journal.pone.0025308. View

Kuschner R, Russell K, Abuja M, Bauer K, Faix D, Hait H . A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits. Vaccine. 2013; 31(28):2963-71. DOI: 10.1016/j.vaccine.2013.04.035. View

Kolavic-Gray S, Binn L, Sanchez J, Cersovsky S, Polyak C, Mitchell-Raymundo F . Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis. 2002; 35(7):808-18. DOI: 10.1086/342573. View

Gray G, Goswami P, Malasig M, Hawksworth A, Trump D, Ryan M . Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group. Clin Infect Dis. 2000; 31(3):663-70. DOI: 10.1086/313999. View

Radin J, Hawksworth A, Blair P, Faix D, Raman R, Russell K . Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis. 2014; 59(7):962-8. DOI: 10.1093/cid/ciu507. View

Hoke Jr C, Hawksworth A, Snyder Jr C . Initial assessment of impact of adenovirus type 4 and type 7 vaccine on febrile respiratory illness and virus transmission in military basic trainees, March 2012. MSMR. 2012; 19(3):2-4. View

10.

ODonnell F, Taubman S . Follow-up analysis of the incidence of acute respiratory infections among enlisted service members during their first year of military service before and after the 2011 resumption of adenovirus vaccination of basic trainees. MSMR. 2016; 22(12):2-7. View

11.

GRAYSTON J, Johnston P, LOOSLI C, Smith M, WOOLRIDGE R . Neutralizing and complement fixing antibody response to adenovirus infection. J Infect Dis. 1956; 99(2):199-206. DOI: 10.1093/infdis/99.2.199. View

12.

Thaci B, Ulasov I, Wainwright D, Lesniak M . The challenge for gene therapy: innate immune response to adenoviruses. Oncotarget. 2011; 2(3):113-21. PMC: 3092742. DOI: 10.18632/oncotarget.231. View

13.

Yun H, Young A, Caballero M, Lott L, Cropper T, Murray C . Changes in Clinical Presentation and Epidemiology of Respiratory Pathogens Associated With Acute Respiratory Illness in Military Trainees After Reintroduction of Adenovirus Vaccine. Open Forum Infect Dis. 2015; 2(3):ofv120. PMC: 4569648. DOI: 10.1093/ofid/ofv120. View

14.

Gray G, Callahan J, Hawksworth A, Fisher C, Gaydos J . Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis. 1999; 5(3):379-85. PMC: 2640764. DOI: 10.3201/eid0503.990308. View

15.

Potter R, Cantrell J, Mallak C, Gaydos J . Adenovirus-associated deaths in US military during postvaccination period, 1999-2010. Emerg Infect Dis. 2012; 18(3):507-9. PMC: 3309579. DOI: 10.3201/eid1803.111238. View